Search
Organogenesis Holdings Inc
ORGOAdd to Watchlist
1.420USD
+0.060+4.41%
Close 09-18 16:00（ET）
180.79MMarket Cap
LossP/E TTM
Organogenesis Holdings Inc (ORGO) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to Organogenesis Holdings Inc in the past month.
Hold
0 Strong Buy
0 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
2.000USD+36.99%
ORGO Analyst Recommendation Trends
In the current month, ORGO has received 0 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ORGO average Analyst price target in the last month is 2.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
1
1
1
1
0
0
0
0
0
0
1
1
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
1
1
2
2
ORGO Analyst Rating for Peer Comparison
Updated: Sep 18, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
8
13
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, ORGO EPS is projected to reach -0.175 in FY2026Q3, following reported EPS of -0.772 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.21
-0.31
-0.35
-0.17
-0.06
Actual
0.28
-0.44
-0.77
--
--
Surprise
+31.78%
-41.75%
-120.58%
--
--
FAQs
What is Organogenesis Holdings Inc's expected revenue for the next quarter?
Organogenesis Holdings Inc's expected revenue is 52.10M.
What is Organogenesis Holdings Inc's price target?
Analysts forecast that Organogenesis Holdings Inc's price target is USD 2.00, with the highest forecast at USD 2.00 and the lowest forecast at USD 2.00.
How have Organogenesis Holdings IncORGO's recent earnings per share performed?
The market expectation was USD -0.77, while Organogenesis Holdings IncORGO's earnings per share (EPS) for the previous quarter was USD -0.44. EPS for the next quarter is expected at USD -0.17.
What is the analyst rating for Organogenesis Holdings Inc?
Based on the ratings of Organogenesis Holdings Inc's stock from 2 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.